Cargando…

Impact of matrix metalloproteinase-11 gene polymorphisms upon the development and progression of hepatocellular carcinoma

Hepatocellular carcinoma (HCC) is a liver malignancy and a major cause of cancer mortality worldwide. Matrix metalloproteinase-11 (MMP-11), also known as stromelysin-3, plays a critical role during tumor migration, invasion and metastasis. Here, we report on the association between five single nucle...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Bin, Hsu, Chin-Jung, Lee, Hsiang-Lin, Chou, Chia-Hsuan, Su, Chen-Ming, Yang, Shun-Fa, Tang, Chih-Hsin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ivyspring International Publisher 2018
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5930468/ https://www.ncbi.nlm.nih.gov/pubmed/29725257 http://dx.doi.org/10.7150/ijms.23733

Ejemplares similares

The Impact of Matrix Metalloproteinase-11 Polymorphisms on Colorectal Cancer Progression and Clinicopathological Characteristics
por: Huang, Hsien-Cheng, et al.
Publicado: (2022)

Impact of Matrix Metalloproteinase-11 Gene Polymorphisms on Biochemical Recurrence and Clinicopathological Characteristics of Prostate Cancer
por: Hsieh, Chun-Yu, et al.
Publicado: (2020)

Variations in the AURKA Gene: Biomarkers for the Development and Progression of Hepatocellular Carcinoma
por: Wang, Bin, et al.
Publicado: (2018)

High Level of Plasma Matrix Metalloproteinase-11 Is Associated with Clinicopathological Characteristics in Patients with Oral Squamous Cell Carcinoma
por: Hsin, Chung-Han, et al.
Publicado: (2014)

Impact of matrix metalloproteinase-11 gene polymorphisms on development and clinicopathologcial variables of uterine cervical cancer in Taiwanese women
por: Ng, Soo-Cheen, et al.
Publicado: (2019)

Impact of Matrix Metalloproteinases 11 Gene Variants on Urothelial Cell Carcinoma Development and Clinical Characteristics
por: Li, Chien-Chang, et al.
Publicado: (2020)

Impacts of WNT1-inducible signaling pathway protein 1 polymorphism on hepatocellular carcinoma development
por: Chen, Chih-Tien, et al.
Publicado: (2018)

Matrix Metalloproteinase-11 Gene Polymorphisms as a Risk for Hepatocellular Carcinoma Development in Egyptian Patients
por: Saad, Hind, et al.
Publicado: (2020)

Effects of HMGB1 Polymorphisms on the Susceptibility and Progression of Hepatocellular Carcinoma
por: Wang, Bin, et al.
Publicado: (2016)

Matrix metalloproteinase‐9 inhibition or deletion attenuates portal hypertension in rodents
por: Huang, Hui‐Chun, et al.
Publicado: (2021)

Functional relationship between matrix metalloproteinase-11 and matrix metalloproteinase-14
por: Buache, Emilie, et al.
Publicado: (2014)

Genetic Polymorphisms of lncRNA LINC00673 as Predictors of Hepatocellular Carcinoma Progression in an Elderly Population
por: Yuan, Lan-Ting, et al.
Publicado: (2022)

Impacts of CCL4 gene polymorphisms on hepatocellular carcinoma susceptibility and development
por: Wang, Bin, et al.
Publicado: (2017)

Effects of RAGE Gene Polymorphisms on the Risk and Progression of Hepatocellular Carcinoma
por: Su, Shih-Chi, et al.
Publicado: (2015)

Association between Interleukin-18 Polymorphisms and Hepatocellular Carcinoma Occurrence and Clinical Progression
por: Lau, Hon-Kit, et al.
Publicado: (2016)

Matrix metalloproteinase-9 gene polymorphisms in nasal polyposis
por: Wang, Ling-Feng, et al.
Publicado: (2010)

Regulation and Function of Matrix Metalloproteinase-13 in Cancer Progression and Metastasis
por: Li, Shun, et al.
Publicado: (2022)

Molecular interactions of tannic acid and matrix metalloproteinases 2 and 9
por: Chiang, Ya-Tang, et al.
Publicado: (2023)

Influence of angiogenetic factors and matrix metalloproteinases upon tumour progression in non-small-cell lung cancer
por: Shou, Y, et al.
Publicado: (2001)

Positive associations between upregulated levels of stress-induced phosphoprotein 1 and matrix metalloproteinase-9 in endometriosis/adenomyosis
por: Wang, Hsin-Shih, et al.
Publicado: (2018)

Matrix metalloproteinase gene polymorphisms and oral cancer
por: Pereira, Andresa C., et al.
Publicado: (2012)

The Role of Matrix Metalloproteinase Polymorphisms in Ischemic Stroke
por: Chang, Jason J., et al.
Publicado: (2016)

Impact of SRY-Box Transcription Factor 11 Gene Polymorphisms on Oral Cancer Risk and Clinicopathologic Characteristics
por: Yeh, Chia-Ming, et al.
Publicado: (2020)

Genetic Polymorphisms of Matrix Metalloproteinases and Clinical Outcomes in Colorectal Cancer Patients
por: Ting, Wen-Chien, et al.
Publicado: (2013)

Elevated Plasma Matrix Metalloproteinase-9 and Its Correlations with Severity of Disease in Patients with Ventilator-Associated Pneumonia
por: Li, Yia-Ting, et al.
Publicado: (2016)

Mucosa-Associated Lymphoid Tissue Lymphoma Translocation Protein 1 Positively Modulates Matrix Metalloproteinase-9 Production in Alveolar Macrophages upon Toll-Like Receptor 7 Signaling and Influenza Virus Infection
por: Lee, Yu-Hsiang, et al.
Publicado: (2017)

Plasma levels of the tissue inhibitor matrix metalloproteinase-3 as a potential biomarker in oral cancer progression
por: Su, Chun-Wen, et al.
Publicado: (2017)

Evaluation of 11 Scoring Functions Performance on Matrix Metalloproteinases
por: Shamsara, Jamal
Publicado: (2014)

Association of melatonin membrane receptor 1A/1B gene polymorphisms with the occurrence and metastasis of hepatocellular carcinoma
por: Su, Shih-Chi, et al.
Publicado: (2017)

Effect of tissue inhibitor of metalloproteinases-3 genetics polymorphism on clinicopathological characteristics of uterine cervical cancer patients in Taiwan
por: Chung, Jui-Fu, et al.
Publicado: (2022)

AMP-activated protein kinase activation mediates CCL3-induced cell migration and matrix metalloproteinase-2 expression in human chondrosarcoma
por: Hsu, Chin-Jung, et al.
Publicado: (2013)

Impact of ADAM10 gene polymorphisms on hepatocellular carcinoma development and clinical characteristics
por: Shiu, Jr-Shiang, et al.
Publicado: (2018)

The Association of Matrix Metalloproteinase Gene Polymorphisms and Periodontitis: An Overview
por: Alotaibi, Dalal H, et al.
Publicado: (2020)

Elevated Expression of Matrix Metalloproteinase-9 not Matrix Metalloproteinase-2 Contributes to Progression of Extracranial Arteriovenous Malformation
por: Wei, Ting, et al.
Publicado: (2016)

Matrix Metalloproteinase-12 Is Required for Granuloma Progression
por: Mohan, Arjun, et al.
Publicado: (2020)

CD44 Gene Polymorphisms on Hepatocellular Carcinoma Susceptibility and Clinicopathologic Features
por: Chou, Ying-Erh, et al.
Publicado: (2014)

Functional genetic variant of WW domain-containing oxidoreductase (WWOX) gene is associated with hepatocellular carcinoma risk
por: Lee, Hsiang-Lin, et al.
Publicado: (2017)

Apoptosis Signal-Regulating Kinase 1 Is Involved in Brain-Derived Neurotrophic Factor (BDNF)-Enhanced Cell Motility and Matrix Metalloproteinase 1 Expression in Human Chondrosarcoma Cells
por: Lin, Chih-Yang, et al.
Publicado: (2013)

CTGF increases matrix metalloproteinases expression and subsequently promotes tumor metastasis in human osteosarcoma through down-regulating miR-519d
por: Tsai, Hsiao-Chi, et al.
Publicado: (2014)

The Role of Matrix Metalloproteinases in the Epithelial-Mesenchymal Transition of Hepatocellular Carcinoma
por: Scheau, Cristian, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_4ifa7e2i01vfcgk3ooiv2b4ono